The goal of the cross-disciplinary international Hybrid Technology Hub is to develop an open source “organ on a chip” platform that reproduces core functionalities of the human body and allows real time data acquisition upon exposure to therapeutic reagents. A current focus is on energy metabolism regulating organs.
- SARS-CoV-2 and COVID19 research at The Hybrid Technology Hub May 18, 2020
- New article: Inhibition of the prostaglandin D2–GPR44/DP2 axis improves human islet survival and function May 15, 2020
- New article: Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells May 12, 2020